Dr. Bollard is the Bosworth Chair for Cancer Biology, Director of the Center for Cancer and Immunology Research, and Director of the Program for Cell Enhancement and Technologies for Immunotherapy (CETI) at Children’s National Medical Center in Washington, DC. She is
Dr. E. John Wherry is the Director of the Institute for Immunology and Professor of Microbiology at the University of Pennsylvania. Dr. Wherry's expertise focuses on T cell exhaustion in chronic infections and cancer.
Dr. Velculescu is Co-Director of Cancer Biology and Professor of Oncology and Pathology at the Johns Hopkins Kimmel Cancer Center, and is a co-founder of Personal Genome Diagnostics. Dr. Velculescu has made a number of important advances in genomics and
Dr. Armstrong is Chairman of the Department of Pediatric Oncology at the Dana-Farber Cancer Institute, Associate Chief of the Division Hematology/Oncology at Boston Children’s Hospital, and the David G. Nathan Professor of Pediatrics at Harvard Medical School. He is also
Dr. Levine is the Director of the Memorial Sloan Kettering Center for Hematologic Malignancies, Laurence Joseph Dineen Chair in Leukemia Research, Member of the Human Oncology and Pathogenesis Program, and Attending Physician at Memorial Sloan Kettering Cancer Center. Dr. Levine’s
Dr. Mardis is Co-Executive Director of the Institute for Genomic Medicine at Nationwide Children’s Hospital, and holds the Nationwide Foundation Endowed Chair in Genomic Medicine. She also teaches as a Professor of Pediatrics at the Ohio State University College of
Dr. Civin is Director of the Center for Stem Cell Biology and Regenerative Medicine at the University of Maryand School of Medicine, and also serves as Associate Dean for Research. Before coming to UMD, Dr. Civin held the King Fahd
Dr. Roose is Principal Investigator and Vice Chair of Anatomy at the University of California, San Francisco. He is also a co-founder of UCSF’s ImmunoX, and of Seal Biosciences, Inc., and runs an organoid disease to biology team in UCSF’s